| MARITIMA DEL CALLAO | 2025 | 775 | KG | 6R,7R)- 7 - [( 2R) - 2 - phenylacetelyl] amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[ 4.2.0] 6R,7R)- 7 - [( 2R) - 2 - phenylacetelyl] amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[ 4.2.0] MATERIA PRIMA PARA LA FABRICACIÓN DE MEDICAMENTOS COMERCIALIZADO EN | CHINA | CHINA | 41214.3 |
| MARITIMA DEL CALLAO | 2025 | 700 | KG | 6R,7R)- 7 - [( 2R) - 2 - phenylacetelyl] amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[ 4.2.0] 6R,7R)- 7 - [( 2R) - 2 - phenylacetelyl] amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[ 4.2.0] MATERIA PRIMA PARA LA FABRICACIÓN DE MEDICAMENTOS COMERCIALIZADO EN | CHINA | CHINA | 37225.8 |
| AEREA Y POSTAL EX-IAAC | 2025 | 18 | KG | (2S,12Z,14E,16S,17S,18R,19R,20R,(2S,12Z,14E,16S,17S,18R,19R,20R,6,9,17,19-TETRAHYDROXY-23- (2S,12Z,14E,16S,17S,18R,19R,20R,(2S,12Z,14E,16S,17S,18R,19R,20R,6,9,17,19-TETRAHYDROXY-23- MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | CHINA | UNITED STATES | 6350 |
| AEREA Y POSTAL EX-IAAC | 2025 | 50 | KG | 9-[(E)-4-[(2S,3R,4R,5S)-3,4-DIHYDROXY-5-[[(2S,3S)-3-[(2S,3S)-3-HYDROXYBUTAN-2-YL]OXIRAN-2- 9-[(E)-4-[(2S,3R,4R,5S)-3,4-DIHYDROXY-5-[[(2S,3S)-3-[(2S,3S)-3-HYDROXYBUTAN-2-YL]OXIRAN-2- MAATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KI | CHINA | CHINA | 27190 |
| MARITIMA DEL CALLAO | 2025 | 1300 | KG | Methyl 7-chloro-6,7,8-trideoxy-6-({[(2R)-1-methyl, S/M, S/M Methyl 7-chloro-6,7,8-trideoxy-6-({[(2R)-1-methyl-4-propylpyrrolidinium-2-yl]carbonyl}amin thio-beta-L-erythro-octopyrano side chloride MATERIA PRIMA PREPARACION DE MEDICAMENTOS | CHINA | CHINA | 83397.3 |
| AEREA Y POSTAL EX-IAAC | 2025 | 1.989 | KG | COLISTIMETATO SODICO ESTERIL, S/M, S/M COLISTIMETHATE SODIUM MATERIA PRIMA PARA FABRICACIÓN DE MEDICAMENTOS COMERCIALIZADO EN BOU = U | CHINA | SWITZERLAND | 6365.64 |
| MARITIMA DEL CALLAO | 2025 | 725 | KG | (6R,7R)-7-[[(2R)-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]act-2-ene- (6R,7R)-7-[[(2R)-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]act-2-ene- MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN | CHINA | CHINA | 38357.3 |
| MARITIMA DEL CALLAO | 2025 | 450 | KG | (6R,7R)-7-[[(2R)-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]act-2-ene- (6R,7R)-7-[[(2R)-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]act-2-ene- MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN | CHINA | CHINA | 23808 |
| MARITIMA DEL CALLAO | 2025 | 725 | KG | (6R,7R)-7-[[(2R)-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]act-2-ene- (6R,7R)-7-[[(2R)-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]act-2-ene- MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN | CHINA | CHINA | 38357.3 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.001 | KG | COLISTIMETATO SODICO ESTERIL (WORKING STANDARD), S/M, S/M COLISTIMETATO SODICO ESTERIL WS MATERIA PRIMA PARA FABRICACIÓN DE MEDICAMENTO COMERCIALIZADO EN UNIDADES // 1 U = 10MG | CHINA | SWITZERLAND | 1 |
| MARITIMA DEL CALLAO | 2025 | 1000 | KG | Methyl 7-chloro-6,7,8-trideoxy-6-({[(2R)-1-methyl-4-propylpyrrolidinium-2-yl]carbonyl}amin Methyl 7-chloro-6,7,8-trideoxy-6-({[(2R)-1-methyl-4-propylpyrrolidinium-2-yl]carbonyl}amin MATERIA PRIMA PARA FABRICACIÓN DE MEDICAMENTOS. COMERCIALIZADO EN KG | CHINA | CHINA | 63925.9 |
| AEREA Y POSTAL EX-IAAC | 2025 | 5.5 | KG | METHYL7-CHLORO-6,7,8-TRIDEOXY-6-(2S,4R)-1METHYL-4-PROPYLPYRROLIDINE-2-CARBOXAMIDO-1THIO-AL METHYL7-CHLORO-6,7,8-TRIDEOXY-6-(2S,4R)-1METHYL-4-PROPYLPYRROLIDINE-2-CARBOXAMIDO-1THIO-AL MATERIA PRIMA PARA FABRICACIÓN DE MEDICAMENTOS COMERCIALIZADO EN KG | CHINA | CHINA | 1680.03 |